LDR Brachytherapy in Community Practice: Expanding Access Through Collaborative Care October 26, 2026
Theragenics Brachytherapy Recognizes Prostate Cancer Awareness Month with the “I Know My PSA. Do You?” Movement September 17, 2026
New BXTA white paper reinforces the role of focal LDR brachytherapy in localised prostate cancer June 12, 2026
Theragenics and Clarity Pharmaceuticals Partner to Enable Scalable Copper-64 Supply for Next-Generation Diagnostics March 25, 2026
Randomized Trial Supports Dose-De-Escalated Pd-103 LDR Brachytherapy for Low-Risk Prostate Cancer January 7, 2026
Theragenics Brachytherapy is headed to the 36th Annual International Prostate Cancer Update December 5, 2025
